Lipovitan
energy drink
Lipovitan (リポビタン, Ripobitan), marketed in some English-speaking countries under the name Libogen and Livita, is an energy drink manufactured by the Japanese company Taisho Pharmaceutical Co. and its licensee Osotspa. Widely available in Asia, it retails in brown-colored translucent 100 ml bottles and has a distinctive bright yellow color. Lipovitan is marketed to alleviate physical and mental fatigue.
Ingredients
The primary ingredient in the Lipovitan product line is taurine. Stronger formulas of the drink include Lipovitan D, which contains 1000 mg of taurine, 20 mg of nicotinic acid extract (vitamin B3), 5 mg each of vitamin B1, B2 and B6, and 50 mg of caffeine. Lipovitan D Super contains 2000 mg of taurine and 300 mg of arginine. MAXIO contains 3000 mg of taurine. The warning label on all of its products say not to consume more than 100 mL per day.
Lipovitan products are sold in Japan and in stores in countries that carry Asian products.
“Lipovitan” enters the record as energy drink. Crown Archives preserves that source wording while asking what Lipovitan, energy and drink can confirm, complicate or overturn.
Why this record matters
“Lipovitan” is worth following because a concise public description often conceals a longer documentary argument. Here, Lipovitan, energy and drink provides the most credible route into that argument.
The citation trail is more important than the brevity of the summary: it shows where individual claims can be examined in context. The source revision retrieved here is dated Jun 15, 2026. The linked authority identifier is Q175919. None of the 1 selected statements returned an explicit reference. The first chronological checks are 1000 and 2000.
The absence of detail may reflect summary conventions rather than a lack of surviving documentation. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.
- Subject orientation
- Search vocabulary
- Locating named sources
The closest primary source, responsible institution and strongest cited specialist reference.
Three-step research path
- Establish the record: confirm the title “Lipovitan”, its source revision and the description used here.
- Expand the search: follow Lipovitan primary sources, Lipovitan archive and Lipovitan research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Lipovitan”?
- Which institution is responsible for the underlying evidence?
- What terminology or title could unlock a more precise catalogue search?
Search terms from this dossier
This entry incorporates text from “Lipovitan” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.